Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04123561 · ClinicalTrials.gov registry record · Phase 3
Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain
A Phase 3 study of Osteoarthritis of the Knee, sponsored by Taiwan Liposome Company.
- Completed
- Registry status
- Phase 3
- Development phase
- 504
- Enrollment target
- 20
- Study locations
NCT04123561 is a Phase 3 study of Osteoarthritis of the Knee that has completed, run by Taiwan Liposome Company. The registered enrollment target is 504 participants, above the 188-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target (168% higher). The trial reports 20 study locations across 5 states.
The verdict
NCT04123561, a Phase 3 study of Osteoarthritis of the Knee, has completed, sponsored by Taiwan Liposome Company.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 504 participants
- Enrollment target
- 20
- Study locations
Study Summary
Phase 3 randomized, double-blind, placebo- and active comparator-controlled study of TLC599.
Conditions Studied
Interventions
- OTHER Normal Saline
- DRUG TLC599
- DRUG DSP
Study Locations (20)
Florida
- Tampa Bay Medical Research - Clearwater
- University Clinical Research-Deland, Llc Dba Accel Clinical Research - DeLand
- Jacksonville Center For Clinical Research - Jacksonville
- Charter Research, Llc - Lady Lake
- Well Pharma Medical Research Corp - Miami
- Conquest Research, Llc - Orlando
- Progressive Medical Research - Port Orange
- Clinical Research of West Florida - Tampa
Arizona
- Gb Family Care - Phoenix
- Arizona Research Center - Phoenix
- Clinical Research Institute of Arizona Llc - Surprise
- Noble Clinical Research Llc - Tucson
California
- Biosolutions Clinical Research Center - La Mesa
- Translational Reseach Group Inc Dba Providence Clinical Research - North Hollywood
- Prospective Research Innovations Inc - Rancho Cucamonga
- Encompass Clinical Research - Spring Valley
Alabama
- Cahaba Research, Inc - Birmingham
- Affinity Orthopedic Specialists Llc - Birmingham
- Shoals Medical Trials Inc - Sheffield
Connecticut
- Chase Medical Research Llc - Waterbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 504 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2022-02-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04123561
The ClinicalTrials.gov registry entry for NCT04123561 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 504 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 188-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target (168% higher). The listed sponsor is Taiwan Liposome Company, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis of the Knee appearing as the primary indexed condition, and to 3 interventions - of which Normal Saline is the first listed.
NCT04123561 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT04123561 about?
NCT04123561 is a clinical study titled "Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain". Phase 3 randomized, double-blind, placebo- and active comparator-controlled study of TLC599.
What is the current status of trial NCT04123561?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 504 participants. The study started on 2019-11-26. Estimated completion is 2022-02-03.
What conditions does trial NCT04123561 study?
This clinical trial studies the following conditions: Osteoarthritis of the Knee.
What interventions are being tested in trial NCT04123561?
The interventions under investigation include: Normal Saline (OTHER), TLC599 (DRUG), DSP (DRUG).
Who is sponsoring clinical trial NCT04123561?
This trial is sponsored by Taiwan Liposome Company, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04123561 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis of the Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee
ACTIVE NOT RECRUITING · Phase 3
-
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
COMPLETED · Phase 3
-
Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee
COMPLETED · Phase 3
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
RECRUITING · NA
-
A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.